Anxiety, Affective Disorders and Schizophrenia

Research group

Group Leader

Antoni Bulbena Vilarrassa

The group is made up of different researchers involved in clinical work either in hospital and primary care. Although the backbone of the group is the original description (and derivative) of the association between anxiety and the joint hypermobility syndrome (JHS), current lines of research include bipolar illness, schizophrenia, first episode psychosis, cognitive psychotherapy for anxiety, obsessive compulsive disorder, psychiatric emergency services, Hikikomori syndrome and also expert patient. Recently, a very active group of ethological research (Noe syndrome, Pet grief, interaction human–animal, etc.) also joined the group, producing relevant contributions.

Members

Jordi Coletas Juanico (Research)

María Paz Flores Martínez (Researcher)

Miguel Ángel Fullana Rivas (Researcher)

Esperanza González Fernández (Research Assistant)

Ángeles Malagón Amor (Phd Student)

Anna Mané Santacana (Researcher)

Luis Miguel Martín (Researcher)

Anna Merino Torres (Researcher)

Clara Monserrat Diez (Technician)

Guillem Pailhez Vindual (Researcher)

María Inmaculada Ruiz Ripoll (Research)

Purificación Salgado Serrano (Researcher)

María José Tribó Boixareu (Researcher)

 

more info

Main Publications

• Bergé D, Mané A, Salgado P, Cortizo R, Garnier C, Gómez-Pérez L, Diez-Aja C, Bulbena A, Pérez V. Predictors of Relapse and Functioning in First-Episode Psychosis: a Two-Year Follow-Up Study. Psychiat Serv 2016; 67(2): 227-233. IF 2.335. Q1.

• Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M, and PEPs GROUP. A Pharmacovigilance Study In First Episode Of Psychosis; Psychopharmacological Interventions And Safety Profiles In The Peps Project. Int J Neuropsychop 2016; 19(4): pyv121. IF 4.333. Q1.

• Calvo P, Bowen J, Bulbena A, Tobeña A, Fatjó J. Highly Educated Men Establish Strong Emotional Links with Their Dogs: A Study with Monash Dog Owner Relationship Scale (MDORS) in Committed Spanish Dog Owners. PLoS ONE 2016; 11(12): e0168748. IF 3.057. Q1.

• Fullana MA, Harrison BJ, Soriano-Mas C, Vervliet B, Cardoner N, Àvila-Parcet A, Rauda J. Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies. Mol Psychiatr 2016; 21(4): 500-508. IF 13.314. Q1.

• Galindo L, Pastoriza F, Bergé D, Mané A, Picado M, Bulbena A, Robledo P, Pérez V, Vilarroya O, Cloninger CR. Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives. PeerJ 2016; 4: e1651. IF 2.183. Q1.

• Pina-Camacho L, del Rey-Mejías A, Janssen J, Bioque M, González-Pinto A, Arango C, Lobo A, Sarró S, Desco M, Sanjuan J, Lacalle-Aurioles M, Cuesta MJ, Saiz-Ruiz J, Bernardo M, Parellada M, PEPs Group (...Bulbena A, Bergé D...). Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis. Schizophrenia Bull 2016; 42(2): 344-57. IF 7.757. Q1.

• Santacana M, Arias B, Mitjans M, Bonillo A, Montoro M, Rosado S, Guillamat R, Valles V, Pérez V, Forero CG, Fullana MA. Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment. PLoS ONE 2016; 11(6): e0158224. IF 3.057. Q1.

• Treen D, Batlle S, Mollà L, Forcadell E, Chamorro J, Bulbena A, Pérez V. Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence. Schizophr Res 2016; 171(1-3): 166-175. IF 4.453. Q1.

Ongoing Research Projects

• Rehabilitación cognitiva combinada con ejercicio físico en el tratamiento de la esquizofrenia: estudio controlado aleatorizado

− Fondo de Investigación Sanitaria. ISCIII (PI15/00453)

− From 2016 to 2018

− Principal investigator: Mané Santacana, Anna

 

• El recuerdo de la extinción del miedo como biomarcador y predictor de respuesta terapéutica en los trastornos de ansiedad: Estudio mediante resonancia magnética funcional

− Fondo de Investigación Sanitaria. ISCIII (PI12/00273)

− From 2013 to 2016

− Principal investigator: Fullana Rivas, Miguel Ángel

 

• Determinantes clínicos y neurobiológicos de segundos episodios de esquizofrenia. Estudio longitudinal de primeros episodios psicóticos

− Fondo de Investigación Sanitaria. ISCIII (PI11/01433)

− From 2012 to 2016

− Principal investigator: Bulbena Vilarrasa, Antonio

Group’s Recognitions

• Officially recognised as a consolidated research group by the Generalitat de Catalunya: Unitat de Recerca en Psiquiatria (2014-2017)

− Agència de Gestió d’Ajuts Universitaris i de Recerca  (SGR 851)

− Principal investigator: Bulbena Vilarrasa, Antonio

Clinical Trials Signed in 2016

• Estudio multinacional retrospectivo de las historias clínicas para evaluar los patrones de utilización de ADASUVE® (loxapina para inhalación mediante el sistema “staccato”) en personas agitadas en la práctica clínica habitual

− Register: AMDC 204-403/APH-LOX-2014-01

− Principal investigators: Salgado Serrano, Purificación; Campillo Sanz, M. Teresa

C/ Doctor Aiguader, 88

08003 Barcelona

(+34) 93 316 04 00

info@imim.es